Mike Rawlins: NICE drug judgements can be improved

Judgements on which drugs should be paid for by the NHS can be improved, the chair of the National Institute for Health and Clinical Excellence has said.

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of HSJ.co.uk and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here